
Overview
Polfarmex is a Polish manufacturer of generic medications that has been providing high-quality, affordable, and safe pharmacological therapies for 35 years. The company offers prescription and over-the-counter drugs, dietary supplements, and cosmetics, with 80% of its products developed in-house. Polfarmex operates in 15 foreign markets, expanding its presence in Europe and beyond.
- ul. Poleczki 35, 02-822 Warszawa
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $3,407 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 82 days late). All were audited by a statutory auditor.
- 202510/07/2026
- 202411/07/2025
- 202311/07/2024
- 202210/07/2023
- 202105/10/2022
- 202005/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Prescription medicines
- Over-the-counter medicines
- Dietary supplements
- Biologic medicines
Websites
The sites are available in: Polish and English.
- polfarmex.plPolfarmex S.A.WordPress 7.1ElementorYoast SEOApache
- bezzakazen.plZakażenia grzybicze – rodzaje grzybicy, porady, testyWordPress 7.1Google AnalyticsGoogle Tag ManagerLLiteSpeed
- polfarmex-intranet.plPolfarmex S.A.Apache
Public procurement
No recorded participation in tenders.
The company is the contractor in one public sector contract, worth USD 2.70k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Aug 20, 2026 | Sponsorship agreement for Święto Róży 2026 | $2,701 | Kutnowski Dom Kultury |
Trademarks
The company holds 159 active trademarks registered with the Polish Patent Office. 1 application is pending. 84 marks have expired or were not registered. The first mark was filed in 1998.
| Mark | Protected until | |
|---|---|---|
| ŻUK (word) | Oct 25, 2035 | |
| DIAZARD (word) | Jul 7, 2035 | |
| FLUXOGIN (word) | May 29, 2035 | |
| APROPOL (word) | Aug 9, 2033 | |
| CALCIFOS (word) | Aug 9, 2033 |
Job offers
The company has its own careers page: polfarmex.pl.
Authorized Representatives
Manner of representation
Authorised to make declarations of will on behalf of the company are: 1) the President of the Management Board independently; 2) two members of the management board acting jointly; 3) a member of the management board acting jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
| 28,363.05 USD | 46.6667% | |||
Drive Technologies sp. z o.o. | 310.64 USD | 23% |
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
94 1160 2202 0000 0000 7623 5389
74 1160 2202 0000 0000 7995 6863
71 1160 2202 0000 0000 7995 6917
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $1.5M$1,538,438 |
Buildings and premises | $25M$24,964,737 |
Investment property | $43,787$43,787 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 26, 2022 | Commercial Companies Code notice | |
| May 23, 2016 | Merger plan | |
| Aug 5, 2015 | Transformation registered |
Public aid
20 public aid cases recorded, with a total value of $2,102,857.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 13, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $26,061$26,061 | Certes sp. z o.o. | |
| May 27, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $10,905$10,905 | Starosta Powiatu Kutnowskiego | |
| Jan 19, 2023 | Aid for research and development projects: experimental development | $400.2K$400,150 | Prezes Agencji Badań Medycznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active | ||
| Integrated permit | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o. | $102,266,019.67 | lekam.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Sandoz Polska sp. z o.o. | $89,136,265.74 | sandoz.com | ||
| Orifarm Manufacturing Poland sp. z o.o. | $83,999,052.46 | orifarm.com | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| SUN-Farm sp. z o.o. | $51,063,341.52 | sunfarm.pl | ||
| Poznańskie Zakłady Zielarskie Herbapol S.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Tactica Pharmaceuticals sp. z o.o. | $28,095,609.42 | tactica.pl |
FAQ
Last updated: 2026-07-16



